Soleus Capital Management »

Adlai Nortye Ltd Sponsored shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Adlai Nortye Ltd Sponsored (ANL) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Adlai Nortye Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Adlai Nortye Ltd Sponsored held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adlai Nortye Ltd Sponsored by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.7M 406k 11.50

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Celcuity (CELC)
Tg Therapeutics (TGTX)
Insulet Corporation (PODD)
Novocure Ord Shs (NVCR)
United Therapeutics Corporation (UTHR)
Inspire Med Sys (INSP)
Rigel Pharmaceuticals (RIGL)
Biosante Pharmaceuticals (ANIP)
Beta Bionics (BBNX)
Vericel (VCEL)
Praxis Precision Medicines I Com New (PRAX)
Geron Corporation (GERN)
Alkermes SHS (ALKS)
Erasca (ERAS)

View all positions for Soleus Capital Management

Top funds holding Adlai Nortye Ltd Sponsored

Cormorant Asset Management
VR Adviser
Balyasny Asset Management
Point72 Asset Management
MPM Oncology Impact Management
Perceptive Advisors
Casdin Capital
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Braidwell
Squadron Capital Management
Eventide Asset Management
Superstring Capital Management
Adage Capital Partners GP

View all funds holding Adlai Nortye Ltd Sponsored